Elixiron Immunotherapeutics Inc.
2 clinical trials · Sponsor
◉ Watch Elixiron Immunotherapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients (NCT06745583) | Elixiron Immunotherapeutics Inc. | 2024-12-16 |
| A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers (NCT04238364) | Elixiron Immunotherapeutics Inc. | 2019-12-27 |
Track Elixiron Immunotherapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.